Gilead Sciences, Inc. (GILD)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous Close | 65.27 |
| Open | 65.50 |
| Bid | 65.37 x 800 |
| Ask | 65.50 x 800 |
| Day's Range | 64.64 - 66.35 |
| 52 Week Range | 64.64 - 87.87 |
| Volume | |
| Avg. Volume | 7,349,480 |
| Market Cap | 81.577B |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | 14.54 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | 3.08 (4.72%) |
| Ex-Dividend Date | Mar 14, 2024 |
| 1y Target Est | N/A |
- Investor's Business Daily
Gilead Gives Up Big Gains As Covid Drug Drives Its Beat — Again
Gilead stock pared its gains Friday after beating first-quarter sales forecasts on the back of its Covid treatment, Veklury.
- Zacks
Gilead (GILD) Q1 Loss Narrower Than Expected, Sales Beat
Gilead (GILD) reports narrower-than-expected loss in the first quarter. Its sales beat estimates on higher HIV, Oncology and Liver Disease sales.
- Thomson Reuters StreetEvents
Q1 2024 Gilead Sciences Inc Earnings Call
Q1 2024 Gilead Sciences Inc Earnings Call
© 2024 Yahoo. All rights reserved.